Data / Form D filings / Remedy Plan, Inc.
Remedy Plan, Inc.: Form D filings
Remedy Plan, Inc., a biotechnology company in Gaithersburg, MD, filed 3 Form D notices with the SEC between 2018 and 2023. The latest, on August 10, 2023, reports $19.1 million sold of a $19.6 million offering to 22 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 704 Quince Orchard Rd, Suite 220, Gaithersburg, MD, 20878
- Phone
- (240) 459-3985
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1757460
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 10, 2023 | New notice | $19,579,386 | $19,069,387 | $509,999 | 22 | Jul 28, 2023 | sec.gov |
| Dec 2, 2019 | New notice | $7,200,000 | $5,200,000 | $2,000,000 | 10 | Nov 12, 2019 | sec.gov |
| Nov 20, 2018 | New notice | $1,500,000 | $1,500,000 | 6 | Nov 9, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Owen Hughes | Director | |
| Frank McCormick | Director | |
| Gregory Crimmins | Executive Officer, Director | |
| Alexandra Manick | Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Aug 7, 2023 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Remedy Plan, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.